H. Takayama et al. / Tetrahedron 56 (2000) 3145±3151
3149
The 1H NMR spectrum of distilled 8 indicated the presence
of a single isomer. The presence of the diastereomer of 8,
i.e. (2R, 3R)-8 and/or (2S, 3S)-8, could not be observed by
comparison with that of the diastereomeric mixture
prepared by m-CPBA oxidation of the racemic alcohol 7.
To determine the optical purity of 8, p-bromobenzoyl
derivative {FABMS (NBA) m/z: 301 ([M13]1), 299
([M11]1). HR-FABMS (NBA): Calcd for C13H16O379Br:
299.0283; found: 299.0288, calcd for C13H16O381Br:
301.0262; found: 301.0250} were prepared by conventional
method. They were analyzed by HPLC using a chiral
column chromatography (Chiral Cel OB, Daicel Chemical
Industries Ltd, solvent; 1% iso-propanol in n-hexane, ¯ow
rate; 0.5 mL/min, column temperature; 308C). The benzoate
derived from optically active 8 obtained by above reaction
exhibited one peak at 26.0 min; on the other hand, the
benzoate derivative containing (2S, 3R)-8 and (2R, 3S)-8
gave two peaks at 20.9 min and 26.0 min, revealing that
the enantiomeric excess of 8 obtained by the Sharpless
epoxidation was .99%.
6.48 (1H, d, J8.0 Hz, H-6), 3.92 (3H, s, ±OCH3), 3.88
(2H, dd, J7.6, 7.6 Hz, H2-3), 3.09 (2H, dd, J7.6,
7.6 Hz, H2-4). 13C NMR (100 MHz, CDCl3) d: 155.51,
151.29, 138.21, 126.97, 125.57, 116.64, 116.20, 104.99,
99.94, 55.23, 48.56, 20.67. EIMS m/z (%): 200 (M1, 100),
199 (92), 184 (24), 149 (26), 105 (48). HR-EIMS: Calcd for
C12H12ON2: 200.0950, found: 200.0959.
Synthesis of the tetracyclic ketone (5a and 5b). A solution
of (2)-epoxide (4) (194 mg, 1.70 mmol) and 5-methoxy-
3,4-dihydro-b-carboline (11) (167 mg, 0.84 mmol) in dry
MeOH (3 mL) was heated under re¯ux for 5 h under
argon atmosphere. The reaction mixture was cooled and
then poured onto the saturated aqueous NaHCO3. The
whole was extracted with CHCl3 three times. The combined
organic layer was washed with brine, dried over MgSO4 and
evaporated. The residue was separated by SiO2 column
chromatography (n-hexane/AcOEt 3:1) to give 5a
(85.3 mg, 33%) and 5b (43.4 mg, 17%). Major isomer 5a
(more polar compound); colorless amorphous powder. UV
(MeOH) lmax (log e): 293 (3.82), 286 (sh, 3.84), 268 (3.96),
225 (4.58) nm. IR nmax (KBr): 3316, 2943, 2700±2840,
Preparation of (2)-ketone (4) by Swern oxidation of car-
binol (8). To a stirred solution of oxalyl chloride (0.75 mL,
8.60 mmol) in dry CH2Cl2 (20 mL) was added dropwise
DMSO (1.2 mL, 16.91 mmol) in dry CH2Cl2 (7 mL) at
2788C under argon atmosphere. After stirring the reaction
1
1721, 1621, 1569, 1510, 1462, 1348, 1257, 1104 cm21. H
NMR (500 MHz, CDCl3) d: 7.74 (1H, br.s, Na-H), 7.06 (1H,
dd, J7.9, 7.9 Hz, H-11), 6.93 (1H, d, J7.9 Hz, H-12),
6.49 (1H, d, J7.9 Hz, H-10), 4.05 (1H, s, ±OH), 3.89
(3H, s, ±OCH3), 3.82 (1H, m, H-3), 3.11±3.20 (2H, each
m, H-5 and H-6), 3.07 (1H, d, J11.9 Hz, H-21), 3.04±3.09
(1H, m, H-6), 3.03 (1H, dd, J13.7 Hz, 10.4, H-14), 2.84±
2.91 (1H, m, H-5), 2.77 (1H, dd, J13.7 Hz, 4.1, H-14),
2.65 (1H, d, J11.9 Hz, H-21), 1.89±1.97 (1H, m, H-19),
1.62±1.70 (1H, m, H-19), 0.96 (3H, dd, J7.5, 7.5 Hz,
H-18). 13C NMR (125 MHz, CDCl3) d: 207.92 (C-15),
154.52 (C-9), 137.49 (C-13), 130.24 (C-2), 122.89 (C-11),
117.03 (C-8), 108.47 (C-7), 104.38 (C-12), 100.02 (C-10),
79.38 (C-20), 63.33 (C-21), 58.56 (C-3), 55.24 (-OCH3),
52.05 (C-5), 41.96 (C-14), 25.47 (C-19), 23.16 (C-6), 7.08
(C-18). EIMS m/z (%): 314 (M1, 100), 313 (63), 214 (95),
200 (70), 186 (46). HR-FABMS: Calcd for C18H23O3N2:
315.1709, found: 315.1700. [a]2D4187.6 (c 0.27, CHCl3).
CD (0.41 mM, MeOH, 268C), lnm (De): 337 (0), 310
(11.3), 296 (0), 291 (sh, 21.2), 284 (sh, 21.4), 267
(22.5), 246 (21.4), 234 (22.6), 230 (0), 219 (112.3),
203 (0). Minor isomer 5b (less polar compound); pale
yellow amorphous powder. UV (MeOH) lmax (log e): 293
(3.90), 282 (sh, 3.91), 266 (4.02), 225 (4.59) nm. IR nmax
(KBr): 3316, 2943, 2700±2830, 1721, 1621, 1510, 1462,
mixture for 30 min,
a solution of (2)-8 (800 mg,
6.90 mmol) in dry CH2Cl2 (12 mL) was added dropwise,
and the reaction mixture was stirred for 1.5 h at 2788C.
Then Et3N (4.8 mL, 34.44 mmol) was added, and the reac-
tion mixture was allowed to warm to room temperature
gradually. Water (25 mL) was added to the reaction
mixture. The organic layer was separated, and the aqueous
layer was extracted with Et2O three times. The combined
organic layer was washed with water, dried over MgSO4 and
concentrated to ca. 20 mL under 200 mmHg at 15±218C.
The residue was distilled under reduced pressure (44±
818C, 82±96 mmHg) to afford 327 mg (41%) of the ketone
4 as a colorless oil. [a]2D4258 (c 0.54, CHCl3). IR nmax
(neat): 3750, 1704, 1642 cm21. 1H NMR (400 MHz, CDCl3)
d: 2.93 (1H, d, J4.9 Hz, H-1), 2.89 (1H, d, J4.9 Hz,
H-1), 2.04 (3H, s, ±COCH3), 2.14, 1.64 (2H, each m,
H2-3), 0.94 (3H, ddd, J7.5, 7.5 Hz, 0.8, H3-4). 13C NMR
(125 MHz, CHCl3) d: 207.7, 63.29, 50.44, 23.87, 23.00,
8.63.
Preparation of 5-methoxy-3,4-dihydro-b-carboline (11).
To a solution of Nb-formyl-4-methoxytryptamine (10)
(869 mg, 3.99 mmol) (which was prepared by condensation
of 4-methoxytryptamine (9) and formic acid, in CH3CN
(10 mL)) POCl3 (500 mL, 5.36 mmol) was added at 08C
and the reaction mixture was heated under re¯ux for 1 h
under argon atmosphere. The reaction mixture was concen-
trated under reduced pressure and the residue was dissolved
in aqueous 1 N HCl solution. The insoluble material was
®ltered off and the ®ltrate was alkali®ed with aqueous conc.
NH3 solution. By suction ®ltration of the resulting precipi-
tate, 11 (518 mg, 65%) was obtained as yellow amorphous
powder. UV (MeOH) lmax: 349, 317, 249, 220, 208,
205 nm. IR nmax (KBr): 3185, 1623, 1580, 1544, 1519,
1
1348, 1104 cm21. H NMR (500 MHz, CDCl3) d: 7.66
(1H, br.s, Na-H), 7.06 (1H, dd, J8.1, 8.1 Hz, H-11), 6.93
(1H, d, J8.1 Hz, H-12), 6.49 (1H, d, J8.1 Hz, H-10),
3.89 (3H, s, ±OCH3), 3.79 (1H, s, OH), 3.53±3.57 (1H,
m, H-3), 3.22 (1H, d, J11.3 Hz, H-21), 3.13±3.18 (1H,
m, H-6), 3.08±3.12 (1H, m, H-5), 3.03±3.07 (1H, m,
H-6), 2.82 (1H, dd, J13.3, 3.2 Hz, H-14), 2.75 (1H, dd,
J13.3, 11.9 Hz, H-14), 2.64±2.69 (1H, m, H-5), 2.53 (1H,
d, J11.3 Hz, H-21), 2.21±2.30 (1H, m, H-19), 1.81±1.89
(1H, m, H-19), 0.82 (3H, dd, J7.5, 7.5 Hz, H-18). 13C
NMR (125 MHz, CDCl3) d: 211.22 (C-15), 154.54 (C-9),
137.51 (C-13), 130.63 (C-2), 122.82 (C-11), 117.08 (C-8),
108.99 (C-7), 104.29 (C-12), 100.01 (C-10), 79.35 (C-20),
65.97 (C-21), 59.74 (C-3), 55.25 (-OCH3), 52.15 (C-5),
42.97 (C-14), 30.67 (C-19), 23.94 (C-6), 6.94 (C-18).
EIMS m/z (%): 314 (M1, 96), 313 (52), 214 (100), 200
1
1425, 1373, 1262, 1174, 1107 cm21. H NMR (400 MHz,
CDCl3) d: 8.55 (1H, br.s, Na-H), 8.33 (1H, br.s, H-1), 7.17
(1H, dd, J8.0, 8.0 Hz, H-7), 6.97 (1H, d, J8.0 Hz, H-8),